This week on Higher Exchanges, we dive into the chaos and clarity surrounding cannabis reform, capital markets, and hemp regulation. Joining us is Scott Grossman of Turning Point Brands for a timely roundtable on what’s real, what’s noise, and what could actually move the needle.🔍 Topics include:<ul><li>Schedule 3 speculation: Who’s driving the renewed chatter, and what do Appropriations moves, VA access, and the DEA vote on Terrance Cole really mean?</li><li>Political chessboard: Will cannabis reform matter to Trump in 2025? Does it poll high enough to compete with narratives like firing Jay Powell?</li><li>Operator strategy: Is Schedule 3 enough to spark M&A or fresh capital without top-line growth? Who benefits—and who doesn’t?</li><li>Reform-dependent vs. reform-independent: MSOs, tier ones, Canadian LPs, and the small-cap battleground</li></ul>Late in the episode, the audio begins to echo. We apologize and did our best to fight through it!

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Know What You Own Starring Scott Grossman

Higher Exchanges

AI Chapters

AI Insights

Reviews